Full evaluation of an acquired case of thrombotic thrombocytopenic purpura following the surgical resection of glioblastoma multiforme

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 12, 2006, Pages 2733-2737

  Cataland, S R ^a   Jin, M ^a   Smith, E ^a   Stanek, M ^a   Wu, Haifeng M ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BILIRUBIN; D DIMER; HAPTOGLOBIN; HEMOGLOBIN; LACTATE DEHYDROGENASE; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CRANIOTOMY; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE; GENERAL CONDITION DETERIORATION; GLIOBLASTOMA; HEADACHE; HEMIPARESIS; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; KIDNEY FAILURE; LABORATORY TEST; MENTAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT CANCER; REMISSION; SEIZURE; THROMBOTIC THROMBOCYTOPENIC PURPURA; TUMOR VOLUME;

ADAM PROTEINS; AUTOANTIBODIES; CRANIOTOMY; FATAL OUTCOME; FEMALE; GLIOBLASTOMA; HUMANS; MIDDLE AGED; PLASMA EXCHANGE; PLATELET COUNT; PURPURA, THROMBOTIC THROMBOCYTOPENIC; TIME FACTORS;

EID: 33750970030     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.02217.x     Document Type: Article

References (48)

1. George JN. Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med 2006; 354: 1927-35.
2. Moake JL. Thrombotic microangiopathies. N Engl J Med 2002; 347: 589-600.
3. Sadler JE, Moake JL, Miyata T, George JN. Recent advances in thrombotic thrombocytopenic purpura. Hematology (Am Soc Hematol Educ Program) 2004; 407-23.
4. Dong JF, Moake JL, Nolasco L, Bernardo A, Arceneaux W, Shrimpton CN, Schade AJ, McIntire LV, Fujikawa K, Lopez JA. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood 2002; 100: 4033-9.
5. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, Lammle B. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998; 339: 1578-84.
6. Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998; 339: 1585-94.
7. George JN, Sadler JE, Lammle B. Platelets: Thrombotic thrombocytopenic purpura. Hematology 2002; 315-34.
8. Tsai HM. Platelet activation and the formation of the platelet plug: deficiency of ADAMTS13 causes thrombotic thrombocytopenic purpura. Arterioscler Thromb Vasc Biol 2003; 23: 388-96; Epub 2003 Jan. 2030.
9. Vesely SK, George JN, Lammle B, Studt JD, Alberio L, El-Harake MA, Raskob GE. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: Relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood 2003; 102: 60-8.
10. May Jr HV, Harbert Jr GM, Thornton Jr WN. Thrombotic thrombocytopenic purpura associated with pregnancy. Am J Obstet Gynecol 1976; 126: 452-8.
11. Caggiano V, Fernando LP, Schneider JM, Haesslein HC, Watson-Williams EJ. Thrombotic thrombocytopenic purpura: Report of fourteen cases-occurrence during pregnancy and response to plasma exchange. J Clin Apher 1983; 1: 71-85.
12. Upshaw Jr JD, Reidy TJ, Groshart K. Thrombotic thrombocytopenic purpura in pregnancy: Response to plasma manipulations. South Med J 1985; 78: 677-80.
13. Natelson EA, White D. Recurrent thrombotic thrombocytopenic purpura in early pregnancy: Effect of uterine evacuation. Obstet Gynecol 1985; 66: 54S-6S.
14. Niv E, Segev A, Ellis MH. Staphylococcus aureus bacteremia as a cause of early relapse of thrombotic thrombocytopenic purpura. Transfusion 2000; 40: 1067-70.
15. Coppo P, Adrie C, Azoulay E, Leleu G, Oksenhendler E, Galicier L, Le Gall JR, Bussel A, Schlemmer B. Infectious diseases as a trigger in thrombotic microangiopathies in intensive care unit (ICU) patients? Intensive Care Med 2003; 29: 564-9.
16. Riegert-Johnson DL, Sandhu N, Rajkumar SV, Patel R. Thrombotic thrombocytopenic purpura associated with a hepatic abscess due to Actinomyces turicensis. Clin Infect Dis 2002; 35: 636-7.
17. Muniz AE, Barbee RW. Thrombotic thrombocytopenic purpura (TTP) presenting as pancreatitis. J Emerg Med 2003; 24: 407-11.
18. Talwalkar JA, Ruymann FW, Marcoux P, Farraye FA. Recurrent thrombotic thrombocytopenic purpura (TTP) as a complication of acute relapsing pancreatitis. Dig Dis Sci 2002; 47: 1096-9.
19. Varadarajulu S, Ramsey WH, Israel RH. Thrombotic thrombocytopenic purpura in acute pancreatitis. J Clin Gastroenterol 2000; 31: 243-5.
20. Daryanani S, Wilde JT. Relapsing thrombotic thrombocytopenic purpura in association with recurrent pancreatitis. Clin Lab Haematol 1998;20: 317-8.
21. Jackson B, Files JC, Morrison FS, Scott-Conner CE. Thrombotic thrombocytopenic purpura and pancreatitis. Am J Gastroenterol 1989; 84: 667-9.
22. Boyer A, Chadda K, Salah A, Bonmarchand G. Thrombotic microangiopathy: an atypical cause of acute renal failure in patients with acute pancreatitis. Intensive Care Med 2004; 30: 1235-9.
23. Ruiz J, Koduri PR, Valdivieso M, Shah PC. Refractory post-pancreatitis thrombotic thrombocytopenic purpura: Response to rituximab. Ann Hematol 2005; 84: 267-8.
24. Forman RB, Benkel SA, Novik Y, Tsai HM. Presence of ADAMTS13 activity in a patient with metastatic cancer and thrombotic microangiopathy. Acta Haematol 2003; 109: 150-2.
25. Pirrotta MT, Bucalossi A, Forconi F, Bocchia M, Mazzotta S, Sammassimo S, Gozzetti A, Lauria F. Thrombotic thrombocytopenic purpura secondary to an occult adenocarcinoma. Oncologist 2005; 10: 299-300.
26. Sugimoto T, Saigo K, Shin T, Kaneda Y, Manabe N, Narita H, Wakuya J, Imoto S, Murayama T, Matsumoto M, Fujimura Y, Nishimura R, Koizumi T, Kumagai S. Von Willebrand factor-cleaving protease activity remains at the intermediate level in thrombotic thrombocytopenic purpura. Acta Haematol 2005; 113: 198-203.
27. Zheng XL, Kaufman RM, Goodnough LT, Sadler JE. Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura. Blood 2004; 103: 4043-9.
28. Wolff D, Brinkmann B, Emmrich J, Steiner M. Metastatic pancreatic carcinoma presenting as thrombotic thrombocytopenic purpura. Pancreas 2003; 26: 314.
29. Alexopoulou A, Dourakis SP, Nomikou E. Case of thrombotic thrombocytopenic purpura associated with disseminated gastric cancer. Am J Clin Oncol 2002; 25: 632.
30. Blot E, Decaudin D, Veyradier A, Bardier A, Zagame OL, Pouillart P. Cancer-related thrombotic microangiopathy secondary to Von Willebrand factor-cleaving protease deficiency. Thromb Res 2002; 106: 127-30.
31. Robson MG, Abbs IC. Thrombotic thrombocytopenic purpura following hemicolectomy for colonic carcinoma. Nephrol Dial Transplant 1997; 12: 198-9.
32. Pavlovsky M, Weinstein R. Thrombotic thrombocytopenic purpura following coronary artery bypass graft surgery: Prospective observations of an emerging syndrome. J Clin Apher 1997; 12: 159-64.
33. Snyder Jr HW, Mittelman A, Oral A, Messerschmidt GL, Henry DH, Korec S, Bertram JH, Guthrie Jr TH, Ciavarella D, Wuest D, Perkins W, Balint Jr JP, Cochran SK, Peugeot RL, Jones FR. Treatment of cancer chemotherapy-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome by protein A immunoadsorption of plasma. Cancer 1993; 71: 1882-92.
34. Armstrong MJ, Storch J, Dainiak N. Structurally distinct plasma membrane regions give rise to extracellular membrane vesicles in normal and transformed lymphocytes. Biochimica et Biophysica Acta 1988; 946: 106-12.
35. Qu L, Kiss JE. Thrombotic microangiopathy in transplantation and malignancy. Semin Thromb Hemost 2005; 31: 691-9.
36. Teruya J, Styler M, Verde S, Topolsky D, Crilley P. Questionable efficacy of plasma exchange for thrombotic thrombocytopenic purpura after bone marrow transplantation. J Clin Apher 2001; 16: 169-74.
37. Peyvandi F, Siboni SM, Lambertenghi Deliliers D, Lavoretano S, De Fazio N, Moroni B, Lambertenghi Deliliers G, Mannuccio Mannucci P. Prospective study on the behaviour of the metalloprotease ADAMTS13 and of von Willebrand factor after bone marrow transplantation. Br J Haematol 2006; 134: 187-95.
38. Fontana S, Gerritsen HE, Kremer Hovinga J, Furlan M, Lammle B. Microangiopathic haemolytic anaemia in metastasizing malignant tumours is not associated with a severe deficiency of the von Willebrand factor-cleaving protease. Br J Haematol 2001; 113: 100-2.
39. Jin M, Cataland S, Bissell M, Wu HM. A rapid test for the diagnosis of thrombotic thrombocytopenic purpura using surface enhanced laser desorption/ionization time-of-flight (SELDI-TOF)-mass spectrometry. J Thromb Haemost 2006; 4: 333-8.
40. Scheiflinger F, Knobl P, Trattner B, Plaimauer B, Mohr G, Dockal M, Dorner F, Rieger M. Nonneutralizing IgM and IgG antibodies to von Willebrand factor-cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura. Blood 2003; 102: 3241-3.
41. George JN. The role of ADAMTS13 in the pathogenesis of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clin Adv Hematol Oncol 2005; 3: 627-32.
42. Rodas RA, Fenstermaker RA, McKeever PE, Blaivas M, Dickinson LD, Papadopoulos SM, Hoff JT, Hopkins LN, Duffy-Fronckowiak M, Greenberg HS. Correlation of intraluminal thrombosis in brain tumor vessels with postoperative thrombotic complications: A preliminary report. J Neurosurg 1998; 89: 200-5.
43. Sawaya R, Zuccarello M, Elkalliny M, Nishiyama H. Postoperative venous thromboembolism and brain tumors: Part I. Clinical profile. J Neurooncol 1992; 14: 119-25.
44. Sawaya R, Highsmith RF. Postoperative venous thromboembolism and brain tumors: Part III. Biochemical profile. J Neurooncol 1992; 14: 113-8.
45. Ruff RL, Posner JB. Incidence and treatment of peripheral venous thrombosis in patients with glioma. Ann Neurol 1983; 13: 334-6.
46. Liu F, Feys HB, Dong N, Zhao Y, Ruan C. Alteration of ADAMTS13 antigen levels in patients with idiopathic thrombotic thrombocytopenic purpura, idiopathic thrombocytopenic purpura and systemic lupus erythematosus. Thromb Haemost 2006; 95: 749-50.
47. Rieger M, Ferrari S, Kremer Hovinga JA, Konetschny C, Herzog A, Koller L, Weber A, Remuzzi G, Dockal M, Plaimauer B, Scheiflinger F. Relation between ADAMTS13 activity and ADAMTS13 antigen levels in healthy donors and patients with thrombotic microangiopathies (TMA). Thromb Haemost 2006; 95: 212-20.
48. Shelat SG, Smith P, Ai J, Zheng XL. Inhibitory autoantibodies against ADAMTS-13 in patients with thrombotic thrombocytopenic purpura bind ADAMTS-13 protease and may accelerate its clearance in vivo. J Thromb Haemost 2006; 4: 1707-17.